Rob Davis, Merck CEO (Jeenah Moon/Bloomberg via Getty Images)
February 4, 2025 06:30 AM ESTUpdated 10:47 AM
China
Pharma

Up­dat­ed: Mer­ck tem­porar­i­ly paus­es Gar­dasil ship­ments to Chi­na fol­low­ing sales slow­down

Nicole DeFeudis

Editor

Mer­ck is paus­ing HPV vac­cine ship­ments to Chi­na “un­til at least mid-year” as it grap­ples with low­er de­mand for the shot.

The com­pa­ny al­so with­drew …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Flag­ship spin­out Omega is days away from bank­rupt­cy, fil­ing shows

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

Re­gen­eron will start de­liv­er­ing quar­ter­ly div­i­dends 37 years in­to its ex­is­tence

RFK Jr. ad­vances out of Sen­ate com­mit­tee with Cas­sidy’s sup­port

Astel­las shakes up man­age­ment de­spite im­pres­sive nine-month earn­ings

Up­dat­ed: Pfiz­er sticks to 2025 pro­jec­tions as Covid sales sta­bi­lize, R&D re­vamp con­tin­ues

A service from the Financial Times